Characterization of alveolar soft part sarcoma using a large national database
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute
This publication has 26 references indexed in Scilit:
- Cediranib for Metastatic Alveolar Soft Part SarcomaJournal of Clinical Oncology, 2013
- Radiotherapy for Management of Extremity Soft Tissue Sarcomas: Why, When, and Where?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Long‐term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high‐risk, high‐grade, soft tissue sarcomas of the extremities and body wallCancer, 2010
- Pediatric Nonrhabdomyosarcoma Soft Tissue SarcomasThe Oncologist, 2008
- Should Soft Tissue Sarcomas Be Treated at High-volume Centers?Annals of Surgery, 2007
- Alveolar soft part sarcoma.Archives of Pathology & Laboratory Medicine, 2007
- Alveolar soft-part sarcoma: a review and updateJournal of Clinical Pathology, 2006
- Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IVJournal of Clinical Oncology, 2003
- Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trialThe Lancet, 2002
- The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25Oncogene, 2001